Research projects

Active Italy

Bone cancer

Can AI help cure the most aggressive cancers?

Thanks to you, Dr Sandro Coscanati is exploring a new way to target some of the hardest to treat cancers, including brain and bone cancer. 

Researcher: Dr Sandro Cosconati

Can AI help cure the most aggressive cancers?

Active Italy

General cancer research

Hunting a needle in a haystack: can we spot new targets for cures?

Thanks to you, Dr Paola Scaffidi and her team in Italy have come up with an ingenious new way to spot which genetic changes in cells actually drive cancer which they hope will lead to new life-saving cures. 

Researcher: Dr Paola Scaffidi

Hunting a needle in a haystack: can we spot new targets for cures?

Active Italy

Kidney cancer

Could a missing link lead us to kidney cancer cures?

Thanks to Curestarters, this innovative team in Italy are investigating potential new ways to target kidney cancer.

Researcher: Dr Jean Piero Margaria

Could a missing link lead us to kidney cancer cures?
Sanne Van Neerven Team

Active Netherlands

Bowel cancer

Can we target speedy ‘super-competitor’ cells to stop bowel cancer?

Thanks to you this team in the Netherlands are investigating how inflammation can lead to bowel cancer, and how to stop it. 

Researcher: Dr Sanne van Neerven

Can we target speedy ‘super-competitor’ cells to stop bowel cancer?

Active Switzerland

Lymphoma

Could a powerful new blood cancer treatment help more patients?

Thanks to you, this innovative team are searching for a way to help more patients with an aggressive blood cancer benefit from a cutting-edge new cancer treatment

Researcher: Professor Anne Müller

Could a powerful new blood cancer treatment help more patients?

Active USA

Prostate cancer

Can a new research tool reveal why prostate cancer spreads to the bone?

Thanks to curestarter support, Professor Cynthia Miranti and her team in the United States are using a novel bioengineering method to work out exactly why prostate cancer often spreads to the bone. They hope to improve diagnosis and create better treatments for patients with advanced prostate cancer. 

Researcher: Professor Cynthia Miranti

Can a new research tool reveal why prostate cancer spreads to the bone?

Active USA

Lung cancer

Can we boost immunotherapy for lung cancer using a brand new molecule?

Thanks to curestarter donations, Dr Julien Sage and his team in the US are developing a new treatment to help boost the power of immunotherapy for patients with small cell lung cancer (SCLC). 

Researcher: Dr Julien Sage

Can we boost immunotherapy for lung cancer using a brand new molecule?

Active United Kingdom

Lung cancer

Is there a lung cancer cure living on your skin?

Thanks to curestarter donations Professor Julian Downward and his Curestarter team in London will apply cutting edge technology to create a pioneering cancer vaccine for lung cancer. 

Researcher: Professor Julian Downward

Is there a lung cancer cure living on your skin?

Active Switzerland

Breast cancer

Can combining two drugs spare patients side effects?

Thanks to you, this exciting research in Switzerland is looking at a new drug combination for some of the most common cancers.

Researcher: Professor Thanos Halazonetis

Can combining two drugs spare patients side effects?
We have funded over £220m of research worldwide since 1979 and cancer survival rates have doubled in that time. 

But global funding for discovery research has declined in recent years and we risk losing the cancer cures of the future. Your support can turn the tide. 

Why is discovery research important?

  • 90,436
    Curestarters & counting have helped us fund...
  • 123
    projects in the last five years. But we have had to turn down…
  • 136
    other top ideas due to lack of funding. That's more than...
  • 50%
    of these potential new cancer cures lost.
  • 917
    people chose to become a Curestarter last month. Join them so that one day…
  • 0
    lives will be cut short by cancer.

Donate today to start new cures

Be part of the united effort to stop lives being cut short by cancer.